-
Mashup Score: 15
Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. For Sources of Funding and Disclosures, see page 458. © 2023 American Heart Association, Inc. Originally published August 7,
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 201
/PRNewswire/ — Boston Scientific Corporation (NYSE: BSX) today announced it has received U.S. Food and Drug Administration (FDA) approval for the AGENT™…
Source: www.prnewswire.comCategories: General Medicine News, CardiologistsTweet-
Just out today: First drug-coated balloon for the coronary circulation now approved in the US, for in-stent restenosis. https://t.co/hCVBeRAwA0
-
-
Mashup Score: 4ESC Congress 2023 Amsterdam - 8 month(s) ago
Data Privacy: During the congress your online activity is tracked and collected by the ESC. We use this to award your CME credits; for reporting and statistical purposes; and to provide you with the best experience. Please note your details will be shared with the sponsor of any Industry Session, Tutorial or Exhibition you choose to view. More information is available in the ESC Congress 2023…
Source: esc365.escardio.orgCategories: Cardiologists, Latest HeadlinesTweet-
RT @SmithBIDMC: Catch @SmithBIDMC at #ESCCongress! Replays available on the @escardio site: https://t.co/j0nPjj5ApD https://t.co/nTvcU7iD…
-
-
Mashup Score: 18
Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. The opinions expressed in this article are not necessarily those of the editors or of the American Heart Association. For Sources of Funding and Disclosures, see page 458. © 2023 American Heart Association, Inc. Originally published August 7,
Source: www.ahajournals.orgCategories: Cardiologists, Latest HeadlinesTweet-
It can be difficult to discern high quality observational studies from the rest. But it is critical that we try. Sharing some of the things I've learned here: Bringing the Credibility Revolution to Observational Research in Cardiology | Circulation https://t.co/bOrbpsdkL4
-
-
Mashup Score: 0
Statin therapy is the mainstay of lipid-lowering therapy for the primary prevention of atherosclerotic cardiovascular disease (ASCVD).1 But 5% to 10% of patients are unable to tolerate a statin at any dose or at a dose high enough to achieve patient-specific target levels of low-density lipoprotein…
Source: jamanetwork.comCategories: Cardiologists, Latest HeadlinesTweet-
@drjohnm @kaulcsmc @f2harrell 💯 see the very thoughtful editorial by @kardiologykazi on precisely this issue. https://t.co/X4dHbdr8xD https://t.co/UcWDCwOwIc
-
-
Mashup Score: 2Study Finds Common Complication of Pacemakers Four Times Higher Than Previously Thought - 11 month(s) ago
BIDMC researchers find pacemakers experience common complication of lead-related vein obstructions four times higher than previously thought. Read more.
Source: www.bidmc.orgCategories: Cardiologists, Latest HeadlinesTweet-
RT @BidmcCvi: Incidence of lead-related venous obstruction 4x ⬆️ than previously thought: https://t.co/HyliWI9xj7 New study led by @enric…
-
-
Mashup Score: 5188What I Think About LeBron Breaking My NBA Scoring Record - 1 year(s) ago
Everything You Wanted to Know About LeBron and Me and the Scoring Record
Source: kareem.substack.comCategories: Cardiologists, Latest HeadlinesTweet-
RT @kaj33: My thoughts on @KingJames breaking my record. https://t.co/G3fs3hHlil https://t.co/z61oDX7Z3N
-
-
Mashup Score: 241
Michael LoVuolo, devoted husband, father, brother, uncle and son died unexpectedly at age 58 on Thursday, September 8, 2022 in Marshfield, MA. He is survived by his loving wife Tamara, 4 beautiful children, Sofia, Ava, Mia and Christopher, his parents Ralph Rosemary LoVuolo, his siblings Mark LoVuolo, Lisa Ciesielski and
Source: www.macdonaldfuneralhome.comCategories: Cardiologists, Latest HeadlinesTweet-
Heart broken. Mike was the best in every way. Obituary | Michael LoVuolo of Marshfield, Massachusetts https://t.co/MOnHhHknhU
-
-
Mashup Score: 1
This study will prospectively evaluate the safety and efficacy of Agent DCB in patients treated for coronary ISR.
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
@jedicath @shahrukh_bakar @ShariqShamimMD @jmahmed @mirvatalasnag @DrAsifQasim @SukhNijjer @lamelaspablo @aayshacader @KPujdak @stefan_harb @drandrewsharp @SGuptaMD @ankushg @ProfessorRajeev @INC_CathLab @dimitri_zappi @serioustaurean @DrAmirKaki @evandrofilhobr @Hragy @mmamas1973 @AntoniousAttall @mandeep_mayo @DrJayMohan @JayMathewsMD @BaoGTran @aspergian1 I don’t think it’s due to anything other than no company has tried to submit a PMA application for a coronary DCB in the US, as far as I know. AGENT is the first US IDE trial. (Nearly completed enrollment) https://t.co/mEzTFuSes9
-
-
Mashup Score: 17
In multiple studies, UEAs have been identified as a useful tool in echocardiography, improving study accuracy and reader confidence, while reducing downstream testing and procedures and resulting in significant changes in clinical management. Despite their proven efficacy and cost-effectiveness, rec …
Source: PubMedCategories: Cardiologists, Latest HeadlinesTweet-
RT @DocStrom: Published today @CO_Cardiology (https://t.co/wuf4hMCtwc) - our review of the use of #UEAs in #EchoFirst, impact on downstream…
-
What can medicine learn from @metrics52 and colleagues, and the impact of their work on understanding the causal effects of policies, interventions and treatments? Quite a lot. I wrote a bit about this here. https://t.co/5TnjlJO2ey https://t.co/YjCraJ3Icj